ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

ClinicalTrials.gov ID: NCT05194397

Public ClinicalTrials.gov record NCT05194397. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Intensive Tailored Exercise Training With NAD+ Precursor Supplementation to Improve Muscle Mass and Fitness in Adolescent and Young Adult Hematopoietic Cell Transplant Survivors

Study identification

NCT ID
NCT05194397
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Children's Hospital of Philadelphia
Other
Enrollment
80 participants

Conditions and interventions

Interventions

  • Exercise Intervention Other
  • Nicotinamide Riboside Dietary Supplement
  • Placebo Dietary Supplement

Other · Dietary Supplement

Eligibility (public fields only)

Age range
10 Years to 30 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 22, 2023
Primary completion
Jun 29, 2026
Completion
Jun 29, 2026
Last update posted
Dec 3, 2025

2023 – 2026

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
City of Hope Medical Center Duarte California 91010 Recruiting
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 Recruiting
St. Jude Children's Research Hospital Memphis Tennessee 38105 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05194397, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 3, 2025 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05194397 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →